10 Year ALK+ Lung Cancer Survivor Shares Optimism

Published on

Topics include: Understanding

Dr. Michael Weitz, a 10-year lung cancer survivor, shares his excitement about other developing research in lung cancer treatment. He is particularly enthusiastic about the potential behind liquid biopsies over more invasive surgical methods.

Produced by Patient Power and Antidote in association with the Precision Medicine for Me initiative.

View more programs featuring

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

Dr. Weitz:

Okay.  I'm really excited about liquid biopsies.  I think most people would say immunotherapy, but that's still in its infancy, and I think it still has a long way to go.  But the wonder and the promise of liquid biopsies is that rather than going through invasive testing where you can sample with just a blood draw tumor cells, or DNA of that tumor that is circulating through your body can be captured, and you can make a diagnosis rather than going through biopsies and surgical procedures and all sorts of things that are invasive.  

I think that it too is in its infancy, but we're discovering more and more every day, every month, every year, and I think that's really going to change things.  And especially so because it opens up the window to early detection so that if you're getting blood samples when you're not having any symptoms, I can see the day when you go to your doctor and you go through a cancer screening from a liquid biopsy, what would—that would be incredible impact on early detection.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

Related Programs

Can Lung Cancer Patients Be the Engine for Driving Molecular Testing?

A candid conversation with SURVIVEiT’s Matt Ellefson on finding the best treatment for lung cancer. Tune in now for his expert perspective.

Published:

Janet Freeman-Daily: Patient-to-Patient Power

Taking a few moments out of their collectively busy days, Andrew sat down with Janet Freeman-Daily at the WCLC in Denver to discuss Janet's current participation in an NSCLC ROS1+ Phase I trial and her “takeaways” as a patient and an advocate.

Published:

Should All Lung Cancer Patients Pursue Molecular Testing?

Find your lung cancer tumor’s fingerprint with Precision Medicine and Dr. Fiona Blackhall.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 4, 2017